MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1476-4598
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer ; volume:19 ; number:1 ; day:4 ; month:3 ; year:2020 ; pages:1-15 ; date:12.2020
Molecular cancer ; 19, Heft 1 (4.3.2020), 1-15, 12.2020

Creator
Xu, Juan
Shao, Tingting
Song, Mingxu
Xie, Yunjin
Zhou, Jialiang
Yin, Jiaqi
Ding, Na
Zou, Haozhe
Li, Yongsheng
Zhang, Jiwei
Contributor
SpringerLink (Online service)

DOI
10.1186/s12943-020-01174-w
URN
urn:nbn:de:101:1-2020052321564427193682
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Xu, Juan
  • Shao, Tingting
  • Song, Mingxu
  • Xie, Yunjin
  • Zhou, Jialiang
  • Yin, Jiaqi
  • Ding, Na
  • Zou, Haozhe
  • Li, Yongsheng
  • Zhang, Jiwei
  • SpringerLink (Online service)

Other Objects (12)

Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer

Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer

ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling

ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling

AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma

AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-β signaling pathway in cholangiocarcinoma

G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma

G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy

Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer

Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer

GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway

GPR56 facilitates hepatocellular carcinoma metastasis by promoting the TGF-β signaling pathway

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy

Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy

Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy

MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma

MicroRNA-93 acts as an “anti-inflammatory tumor suppressor” in glioblastoma

Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy

Correction to: Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy

Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy

Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapy

Related objects